The generation of leukotrienes (LTC4, LTD4, LTE4, and LTB4; 12-epi-LTB4 isomer) from human granulocytes by thiol-activated toxins (streptolysin 0, alveolysin from Bacillus alvei, and theta toxin from Clostridium perfringens) is described. The release occurs under noncytolytic conditions. Although LTB4 is the major component after calcium ionophore stimulation, more LTC4 as compared with LTB4 is released with the toxins. The 5-lipoxygenase pathway of toxin-mediated activation can effectively be inhibited by caffeic acid, a lipoxygenase inhibitor. The toxins also induce the release of leukotriene-metabolizing enzymes such as y-glutamyltranspeptidase, which transfers LTC4 into LTD4, and dipeptidase, which metabolizes LTD4, into LTE4. Dipeptidase activity is more pronounced than the -y-glutamyltranspeptidase activity but still does not reach the levels obtained when cells were triggered with opsonized zymosan.
In the past, increasing knowledge has been obtained as to the physiological, genetic, and biochemical mechanisms of pathogenicity. Of great importance are the interactions of lipopolysaccharides, pili, and bacterial exoproducts with the host. It has been described that the sulfhydryl (SH)-activated cytolysins, among which the prototype is streptolysin 0 (SLO), are potent membrane-disrupting agents of eucaryotic cells as evidenced by the morphological damage of cytoplasmic and organelle membranes (7, 17) , inhibition of lymphocyte function, alteration of transport processes, and release of intracellular constituents of target cells such as erythrocytes, platelets, leukocytes, macrophages, and fibroblasts (2, 33) . An important common feature of the toxins is the implication of free thiol groups in their lytic activities, which are suppressed by oxidation of thiol group reagents and restored by reduction. Another essential property shared by the SH-activated toxins is that their cytolytic and lethal activity are specifically and irreversibly inhibited by preincubation with cholesterol and related sterols possessing a 33-OH group and aliphatic side chain of sufficient length at carbon 17 (31) . The reduced form of the toxins binds to specific receptors, which subsequently leads to morphological changes in the cell membrane. In many cases, cytolysins have been shown to be accompanied by the occurrence of circular and semicircular structures on the target membranes. It has been suggested that membrane damage ensued as the result of cholesterol rearrangement and disruption of the bilayer and that the (semi-) circular structures viewed in the electron microscope represented complexes of the toxin with tightly bound cholesterol (3, 16, 18, 30) . Bhakdi et al. (8) reported that SLO polymers generated large transmembrane channels and suggested the classification of SLO as a member of the channel-forming proteins. However, the actual molecular mechanisms of * Corresponding author.
toxin action remains unclear, as does the role played by the free thiol group(s) of the toxin molecule.
It is well established that granulocytes, upon stimulation, generate free arachidonic acid from phospholipids which is metabolized to three groups of derivatives, i.e., the prostaglandins, the thromboxanes, and the leukotrienes which are formed by oxygenation and further transformation (W. Konig, J. Scheffer, K. D. Bremm, J. Hacker, and W. Goebel, Int. Arch. Allergy Appl. Immunol., in press). These mediators which affect vascular permeability, chemotaxis of granulocytes, and smooth muscle contraction are involved in acute and chronic inflammatory disease processes. The biosynthesis of leukotrienes is initiated in a lipoxygenasetype reaction leading to 5-hydroxyperoxyeicosatetraenoic acid (5-HPETE) (29) . This product is the precursor of 5-hydroxyeicosatetraenoic acid (5-HETE) and the leukotriene LTA4. LTA4 can be hydrolyzed to the chemotactic and chemokinetic active compound LTB4 [5(S)-12(R)-dihydroxy-6(cis)-8,10-(trans)-14(cis)-eicosatetraenoic acid] by a hydrolase and nonenzymatically to other dihydroxy acids, e.g., LTB4 isomers with less potent chemotactic activity; to these belong 5(S)-12(R)-6-trans-LTB4 and 5(S)-12(S)-12-epi-6-trans-LTB4 (11, 27) . Alternatively, LTA4 cap conjugate with glutathione to produce LTC4 catalyzed by glutathione S-transferase. LTC4 can be transformed to LTD4 by removal of the -y-glutamyl moiety with the -y-glutamyltranspeptidase. The last step in the metabolism is the cleavage of the carboxy-terminal glycine from LTD4 to form LTE4 by LTD4 dipeptidase (22, 28) .
In the past, we presented evidence that various stimuli induce lipid chemotactic factor activity from human granulocytes, e.g., the calcium ionophore, the phagocytosis of opsonized zymosan, and the interaction of the cells with phospholipase and arachidonic acid (15, 21 In addition, the effect of the toxins on the leukotrieneinducing and -metabolizing enzymes was analyzed.
MATERIALS AND METHODS
Preparation of cells. Human polymorphonuclear leukocytes (PMNs) were obtained from heparinized blood (300 U/ml) of healthy donors and separated on a Ficoll-metrizoate cushion, followed by dextran sedimentation (10) . The cells were washed at 1,400 rpm (300 x g) to remove the platelets. The erythrocytes were lysed by hypotonic exposure of the cell suspension. This method leads to more than 97% pure PMNs. PMNs (107/0.5 ml of buffer) were incubated with the various toxins in the presence of CaCl2 (1 mM). Incubation proceeded at 37°C under conditions described in the experiments and was then stopped with 500 p.l of ice-cold phosphate-buffered saline (PBS). Subsequently, the cells were immediately centrifuged at 300 x g for 15 min, and the supernatants were then placed on ice.
Reagents. ATP, NADH, Ficoll 400, lysozyme, phenolphthalein glucuronidate, and caffeic acid were obtained from Sigma, Munich, Federal Republic of Germany. Organic solvents and acetic acid were of high analytical grade (Baker Co., Deventer, The Netherlands). All other chemicals as well as the silica gel plates were of analytical grade (E. Merck AG, Darmstadt, Federal Republic of Germany).
Buffer. Cell experiments were performed in PBS which consisted of NaCl (120 mM), Na2HPO4 (10 mM), and KH2PO4 (3 mM). The pH of the buffer was 7.4.
Toxins. The toxins were previously activated with 20 mM cysteine. The preparation of alveolysin and SLO has been described by Alouf (2) and Geoffroy and Alouf (19) , and that of C. perfringens theta toxin has been described by Thelestam and Mollby (32, 35 With the described extraction procedure, the recovery rates of leukotrienes from 250 pul of cell supernatants were 80 to 85% for LTC4, LTD4, and LTE4; for LTB4, 12-epi-LTB4 recovery rate was 90 to 99.5% (22) . Standard curves of the individual leukotrienes were obtained from five different quantities (5 to 125 ng) and showed the following correlations: LTC4, 0.985; LTD4, 0.995; LTE4, 0.985; and LTB4, 0.999. The detectable minimum quantities were as follows: LTC4, 2 ng; LTD4, 2 ng; LTE4, 2 ng; and LTB4, 1 ng.
RIA for LTC4 and LTB4. In addition to HPLC analysis, all supernatants were studied by radioimmunoassay (RIA) for LTC4 and LTB4. A 200-tA quantity of the supernatants suspended in 30% methanol was evaporated to dryness under nitrogen. The material was then suspended in 100 ,ul of Tris buffer (0.1 M) containing 0.1% gelatin (1). An appropriate antiplasma dilution as well as standard LTB4, LTC4, or unknown samples were added to tubes containing 3H-LTB4 or 3H-LTC4 in a total volume of 0.6 ml. The minimal quantities detected were ca. 50 pg for LTC4 and ca. 20 pg for LTB4. For the LTC4 determination, the cross-reactivity for LTD4 was <35%, and for LTB4 and LTE4 cross-reactivity was <2%. The RIA for LTB4 was obtained from Wellcome Research Laboratories; the cross-reactivity against LTC4 was 2%. The sensitivity for LTB4 was ca. 10 pg. The correlation of HPLC analysis and RIA amounted to r = 0.75 + 0.1 for LTC4 and r = 0.74 + 0.08 for LTB4. The results presented here are derived from HPLC analysis.
Analysis of leukotriene-inducing and -metabolizing enzymes. Lipoxygenase activity in toxin-stimulated cell supernatants was analyzed as described by Koshihara et al. (23) . A 500-p.l quantity of the cell supernatant was incubated with 0.1 p.Ci of [14C]arachidonic acid (58 mM/Ci) in 0.1 ml of PBS.
A stabilization of enzyme activity was obtained with CaCl2 (2 mM) and ATP (2 mM). For inhibition of the lipoxygenase enzyme, caffeic acid or esculetin was added (25) . Incubation proceeded for 10 min and was stopped with 1 ml of acidified methanol. After centrifugation for 2 min in an Eppendorf centrifuge, the supernatants were extracted twice with ether (3 ml) and evaporated to dryness. tified by cochromatography with reference substances. Unless otherwise stated, the amount of radioactive metabolites generated is expressed as a percentage of total radioactivity that was present in the reaction mixture 'M. Stuning, M. Raulf, and W. Konig, Biochem. Pharmacol., in press). For analysis of the leukotriene-transfuwming enzymes (-yglutamyltranspeptidase by LTC4 conversion and LTD4 dipeptidase by LTD4 conversion), 250-,u samples of the stimulated cell supernatants were incubated with synthetic LTD4 for either 30 or 15 min at 37°C, respectively. The incubation was then stopped with 2 ml of acidified methanol and extracted as has been described. Determination of metabolized leukotrienes was performed by HPLC. The -y-glutamyltranspeptidase and LTD4-dipeptidase activities were expressed by the nanogram quantities of generated metabolites (28) . Determination of marker enzymes. Marker enzymes from granulocytes were determined as previously described (21); peroxidase was determined as described by Baggiolini et al.
(6); P-glucuronidase was determined as described by Avila and Convit (5); lysozyme and lactate dehydrogenase were determined as described by Bretz and Baggiolini (13 at a concentration of 10 HU. At (Table 2) . Kinetic experiments were then carried out with SLO and alveolysin. The release pattern was compared with ionophore-stimulated cells (Fig.  1A to C) . With alveolysin (10 HU/ml), an optimal release of LTC4 is observed after 15 min of incubation which declined rapidly after 20 min. As has been observed in the abovedescribed dose-response experiments, the amount of LTB4, LTD4, 12-epi-LTB4, and LTE4 was far less as compared with LTC4. At later times of incubation, LTE4 levels increased steadily. A similar pattern was obtained when SLOstimulated cell supernatants were analyzed. Again, LTC4 release exceeded that of the other leukotrienes and revealed a sharp increase followed by a steady decline after 20 (Fig. 2A) . Human PMNs (107/500 ,ul) were incubated with bacterial toxins at various concentrations. The supernatants were then incubated for 10 min at 37°C with 0.1 ,uCi of [14C]arachidonic acid (1.6 nM) in the presence of CaC12 and ATP. The supernatants were deproteinized and analyzed by thin-layer chromatography. In general, the amount of metabolized arachidonic acid increased at higher concentrations of the toxins. This pattern correlated with the formation of 5-HETE and 5-HPETE. Caffeic acid, an inhibitor of the 5-lipoxygenase pathway, inhibited the formation of 5-HPETE by more than 50%. In the experiments described ( Fig. 2A) , granulocytes were preincubated with caffeic acid (10-6 M) before the cells were stimulated with the toxins. Figure 2A glutamyltranspeptidase and dipeptidase activity into the supernatant which transforms LTC4 into LTD4 and LTD4 into LTE4 (28) . Experiments were then performed with toxin-stimulated PMNs. Cells (107/500 RI) were incubated with 1 HU of SLO, alveolysin, or theta toxin (data not shown). At various times, the supernatant of stimulated cells was obtained. Synthetic LTC4 (80 ng) was added, and incubation proceeded for 60 min at 37°C. -y-Glutamyltranspeptidase enzyme activity was quantitated by turnover studies with synthetic LTC4. It became apparent that almost no LTD4 was generated; the main metabolite which appeared upon incubation was LTE4. Maximal activity was obtained with stimulated cell supernatants after 10 min of incubation.
Of the 80 ng of LTC4 added to the cell supernatant, only 4 to 6 ng of LTC4 was metabolized at toxin concentrations of 14 HU. No further increase was observed with prolonged incubation. In dose-response studies (Table 3) , major yglutamyltranspeptidase activity was obtained with 10 HU of alveolysin (17.5%), 10 HU of SLO (10.1%), and with 33 to 16.5 HU of theta toxin. The fact that only minute amounts of LTD4 were generated and that LTE4 appeared in the supernatant suggested that cell-free supernatants of stimulated cells also contained a potent dipeptidase which rapidly transformed the generated LTD4 into LTE4. To prove this assumption, human granulocytes (107/500 ,ul) were stimulated with various concentrations of the toxins for 15 min at 37°C. Synthetic LTD4 (75 ng) was added to the cell-free supernatants, and the conversion of LTD4 into LTE4 was analyzed after 60 min of incubation (Table 4 ). The dipeptidase activity analyzed from the supernatant was more active as compared with the -y-glutamyltranspeptidase activity. Of 75 ng of synthetic LTD4 incubated with the cell supernatants, SLO at concentrations from 0.1 to 10 HU generated 20.1 ± 4.8 to 40.4 ± 4.1 ng of LTE4; the alveolysin at concentrations from 0.1 to 10 HU generated ca. 28.2 ± 6.1 to 53.7 ± 3.9 ng of LTE4; theta toxin at concentrations from 0.1 to 165 HU generated about 28.6 ± 4.3 to 60.4 ± 2.4 ng of LTE4. A cell sonicate generated 69.6 ng of LTE4 from 75 ng of LTD4. Kinetic studies with SLO (1 HU), alveolysin (0.1 HU), and theta toxin (0.1 HU) emphasized that the major activity was released from granulocytes after 15 to 20 min of incubation. Previously, it has been observed that granulocytes in the presence of PBS released enzyme activity into the supernatant which steadily increased over time (28) . The toxin-induced release however, far exceeded the control values.
DISCUSSION
Our data clearly demonstrate that the three SH-activated toxins lead to leukotriene generation from human PMNs. The leukotriene-inducing enzyme (5-lipoxygenase) as well as leukotriene-metabolizing enzymes which transform LTC4 into LTD4 as well as LTD4 into LTE4 were also detected. It is well established that the various stimuli differ in their ability to induce the release of leukotrienes as well as metabolize enzymes (12, 26, 28) . Since leukotrienes are potent mediators of inflammation which induce vascular permeability, chemotaxis, and smooth muscle contraction, an important role for these mediators in acute and chronic inflammatory processes has been suggested. The release occurs under noncytolytic concentrations as was assessed by the determination of lactate dehydrogenase in the stimulated-cell supernatants. SLO and theta toxins at concentrations of 100 HU showed a clear elevation of lactate dehydrogenase release above the background control. With higher concentrations of the toxins (above 100 HU), even a decrease in leukotriene release was obtained, indicating a metabolization of these compounds (data not shown). Our observation raises the question whether toxins at non-or sublytic concentrations lead to cell activation before the process of irreversible cell death. Indeed Hirayama et al. (20) recently analyzed the cytotoxic action of leukocidin from Pseudomonas aeruginosa. The destruction of rabbit leukocytes by the toxin was reduced in the absence of Ca2+ and stimulated by the addition of calcium ionophore A 23187. Their studies with regard to the labeling and breakdown of phospholipids indicated that the initial action of the toxin was to stimulate phosphatidic acid production, presumably causing a rapid metabolic change of phosphatidylinositol correlating with the activities of phosphatidylinositol-specific phospholipase C and 1,2-diacylglycerol kinase. They also could detect and confirm arachidonic acid release from rabbit leukocyte membrane treated with leukocidin. From our studies, it appears that the toxins induce cells activation with leukotriene release before cell death. The leukotriene release is strictly dependent on exogenous calcium as was recently demonstrated for the calcium ionophore and opsonized zymosan as stimuli (28) . Alouf et al. (4) By subcellular fractionation it became evident that -yglutamyltranspeptidase is associated with the granular and microsomal fractions and that the dipeptidase was correlated with the specific granules (14) . It is apparent from our results that the supernatant of toxin-stimulated cells is able to metabolize exogeneously added LTC4 as well as LTD4 into LTE4, thus indicating the release of those enzymes. Only minute amounts of LTD4 were detected in these experiments. Conversely, the addition of exogeneous synthetic LTD4 to the stimulated cell supernatants induced a transformation into LTE4 by 21, 74.2, and 57.6% when either 1 HU of SLO, alveolysin, or theta toxin were used as stimuli. From these data, it appears that alveolysin is significantly more active in inducing the release of dipeptidase activity from human PMNs. We recently demonstrated that cells stimulated with opsonized zymosan induced the release of y-glutamyltranspeptidase and dipeptidase activity. It became evident that under experimental conditions similar to those described above, exogeneously added LTC4 (80 ng) was metabolized by ca. 100%, and LTD4 was metabolized by about 88% (28) . These data support the notion that, unlike the toxin stimulated neutrophil, the phagocytic stimulus in addition to the release of leukotrienes has the capacity to release large amounts of leukotriene-metabolizing enzymes. It thus appears that phagocytosis is more likely to protect the microenvironment from the effect of inflammatory mediators. In contrast, toxin stimulation of neutrophils is more likely to damage the microenvironment by inducing leukotriene release which is badly metabolized. Recently, evidence has been presented as to two different modes of membrane-damaging action by bacterial thiolactivated toxins. Among the properties in common, similar morphological effects and leakage patterns were noted. Distinct similarities include the effect of thiol-activated toxins on fibroblast membranes. Compared with the other two hemolysins, SLO was about 10 times less active on fibroblasts in relation to erythrocytes. SLO inhibited the uptake of AIB to a low extent, while both theta-toxin and alveolysin drastically inhibited ox-aminoisobutyric acid uptake at concentrations causing almost no release of the nucleotide marker (24) . Our experiments do stress the similarities of the toxins as to their capacity to release leukotrienes. In contrast to the above-mentioned studies, the biochemical processes described here occur at early times of toxin cell interaction and mostly show a maximum of leukotriene release after 5 to 15 min of incubation. As to the release of dipeptidase activity, it appears that alveolysin is more potent than the two other toxins.
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